FDA Inspection 1091860 — IntegReview, Inc. IRB
The FDA completed an inspection of IntegReview, Inc. IRB on May 22, 2019 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 22, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Austin, TX (United States)
Additional Details
IRB